FDA approves the first non-opioid to treat opioid withdrawal symptoms

On Wednesday, the FDA gave the green light to lofexidine (sold under the brand name Lucemyra), after years of success treating recovering addicts in Europe.

Source: the Mail online | Health - May 16, 2018 Category: Consumer Health News Source Type: news